Serum Creatinine-to-Cystatin C Ratio in the Progression Monitoring of Non-alcoholic Fatty Liver Disease

Serum Creatinine-to-Cystatin C Ratio in the Progression Monitoring of Non-alcoholic Fatty Liver Disease

BackgroundThe simultaneous assessment of visceral adiposity and muscle mass might be useful to monitor the risk of non-alcoholic fatty liver disease (NAFLD) progression in large population. We aimed to investigate the value of serum creatinine-to-cystatin C ratio (CCR) in evaluating these two parame...

Full description

Bibliographic Details
Main Authors: Shaobo Li, Jing Lu, Geng Gu, Wenkun Bai, Yafen Ye, Yuqian Bao, Haoyong Yu, Junfeng Han
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Physiology
Subjects:
biomarker
disease progression
non-alcoholic fatty liver disease
psoas muscles
visceral obesity
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2021.664100/full

Internet

https://www.frontiersin.org/articles/10.3389/fphys.2021.664100/full

Similar Items